Skip to main content

Thursday 7 november

The program for EDA 2024 Annual Meeting is still subject to change. Keep an eye on the website for the latest updates.

Room I – Madurozaal

Keynote session day 1: Interprofessional Teamwork

Chair: Thomas Ottens

TimeSubjectSpeaker
09.00 – 09.10
Welcome from the mayor of Madurodam

Mayor of Madurodam

09.10 – 09.20
Welcome from the President

Leiv Otto Watne (President EDA)

09.20 – 10.05
Keynote: Virtual Critical Care, lessons for interprofessional teamwork

Björn Weiss (Charité Universitätsmedizin Berlin, Germany)

10.05 – 10.15
Discussion

10.15 – 10.45
Coffee break

Update: Perioperative Delirium

Chair: Thomas Ottens

TimeSubjectSpeaker
10.45 – 11.10
The 2023 ESAIC postoperative delirium guideline: what’s new?

Björn Weiss (Charité Universitätsmedizin Berlin, Germany)

11.10 – 11.35
Decision science and predicting delirium

Odette Wegwarth (Charité Universitätsmedizin Berlin, Germany)

11.35 – 12.00
Masterclass: Guideline implementation

Erwin Ista (Erasmus MC Rotterdam, The Netherlands)

12.00 – 12.15
Discussion

12.15 – 13.15
Lunch

Artificial Intelligence (AI) in Delirium Research

Chair: Robert Gray

TimeSubjectSpeaker
13.15 – 13.45
Delirium is in the AI of the beholder

Alex Tsui (University College London, UK)

13.45 – 14.15
The fallacy of interpretability: Lessons from Delirium

Parashkev Nachev (University College London, UK)

14.15 – 14.45
Ethics & AI

Michel van Genderen (Erasmus MC Rotterdam, The Netherlands)

14.45 – 15.15
Afternoon coffee break

Long term outcomes in ICU survivors: comparing experiences from the US & Europe

Chair: Mark van den Boogaard

TimeSubjectSpeaker
15.15 – 15.40
Post-Intensive Care Syndrome: Risk Factors, Outcomes, and Development of a Population-Level Risk Score

Sikandar Khan (Indiana University, USA)

15.40 – 16.05
Life after Delirium: Long-term Outcomes in a Large, Community-Based Cohort in the Netherlands

Rens Kooken (Radboudumc, The Netherlands)

16.05 – 16.30
Clinical Trajectories Among Acute Respiratory Failure Survivors with Delirium in the US: A Real-world Experience

Babar Khan (Indiana University, USA)

16.30 – 16.45
Discussion

16.45 – 17.00
Afternoon coffee break

Decision science and predicting delirium

Chair:

TimeSubjectSpeaker
17.00 – 17.25
Health-related quality of life (HRQoL) after PICU admission and the influence of pediatric delirium

Kim Tijssen (Maastricht UMC+, The Netherlands)

17.25 – 17.50
Delirium in the NICU: Fact or Fiction?

Husam Salamah (Maastricht UMC+, The Netherlands)

17.50 – 18.00
Discussion

18.00
End of programme
19.00
Walking dinner

ROOM II – Boon van der Starpzaal

Delirium Pharmacotherapy into the future

Chair:

TimeSubjectSpeaker
10.45 – 11.10
Haloperidol

Mathieu van der Jagt (Erasmus MC Rotterdam, The Netherlands)

11.10 – 11.35
Alpha-2-agonists

Björn Erik Neerland (Universitetssykehus Oslo, Norway)

11.35 – 12.00
Intranasal Insulin

Gideon Caplan (UNSW Sydney, Australia)

12.00 – 12.15
Discussion

12.15 – 13.15
Lunch

Delirium in Special Groups

Chair:

TimeSubjectSpeaker
13.15 – 13.40
Pediatrics: Delirium in Children

Jacqueline Strik (Maastricht University, The Netherlands)

13.40 – 14.05
Geriatrics: Delirium in Dementia & very old age

Daniel Davis (University College London, UK)

14.05 – 14.30
Post-stroke delirium

Sylvie de Raedt (UZ Bruxelles, Belgium)

14.30 – 14.45
Discussion

14.45 – 15.15
Afternoon coffee break

Best Abstract Session I

Chair:

TimeSubjectSpeaker
15.15 – 16.45
Best Abstract Session

16.45 – 17.00
Afternoon coffee break

American Delirium Society – Submitted Symposium

Chair: Noll Campbell/Leiv Otto Watne

TimeSubjectSpeaker
17.00 – 18.00
Organizational, Scientific, And Clinical Updates from the ADS

Noll Campbell

TimeSubjectSpeaker
18.00 – 19.00
EDA General Assembly

ROOM III – Oranjezaal

Best Abstract Session II

TimeSubjectSpeaker
13.15 – 14.45
Workshop Delirium in the palliative phase

Josephine Stoffels, Jenske Geerling, An Reyners, Meera Agar, Lia van Zuylen

Delirium at the end of life often provides specific challenges to health care professionals involved. Since the underlying somatic factors are of a progressive nature, delirium symptoms tend to increase despite standard anti-delirium measures. In this interactive workshop, we will point at tensions between geriatric versus palliative approaches to these patients and provide suggestions to integrate these approaches. Also, we will explore whether early detection with biomarkers could play a beneficial role. Finally, we will examine the roles of antipsychotic and sedating medication.

TimeSubjectSpeaker
15.15 – 16.45
Best Abstract Session